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Introduction
Ligation and stripping was for years the most frequent-
ly employed therapeutic option in the treatment of great 
saphenous vein insufficiency. However, in association 
with technological advances, there has been continu-
al research into treating the disease using endovenous 
methods. Research into sclerosing the venous wall using 
thermal methods in particular has recorded considerable 
progress, and in 2001 Navarro et al published the first 
application of thermal endovenous ablation using an 810 
nm diode laser.1 Since then, there has been increasing 
progress in laser technology, and numerous studies have 
been performed using different wavelengths and types of 
laser.2-7 The Food and Drug Administration (FDA)-ap-
proved lasers today are 810, 940, 980 and 1470 nm diode 
lasers and 1319 and 1320 nm neodymium-doped yttrium 
aluminium garnet (Nd:YAG) lasers. In parallel to advanc-
es in laser technology, studies began being performed 
concerning thermal ablation of the saphenous vein using 
radiofrequency energy, and permission for the use of ra-
diofrequency energy in endovenous ablation was granted 
by the FDA in 1999. In 2002, Weiss and Weiss reported 
the first patients receiving thermal ablation using radiof-
requency energy.8 Numerous studies using radiofrequen-
cy ablation (RFA) were subsequently published.9-11 Stud-
ies comparing endovenous laser ablation (EVLA) and 
RFA then began being published. These studies generally 
reported equal success between EVLA and RFA, albeit 
with fewer side-effects and greater patient satisfaction 
with RFA.12,13 However, all these studies compared laser 
energy at low wavelengths (810, 940 and 980 nm) with ra-
diofrequency. However, high wavelength laser energy and 
radial fiber have been shown to produce better patient 
satisfaction and fewer side-effects compared to low wave-
length laser energy and bare fiber.14 There are no clinical 
studies in the literature comparing laser energy at a wave-
length of 1470 or more with RFA. We therefore planned 
this study in order to assess patients receiving EVLA with 
laser energy at a wavelength of 1470 nm and radial fiber 
and patients receiving RFA in terms of procedure success, 
complications and patient satisfaction. In order to elimi-
nate patient-related variables, EVLA was applied to one 
leg of patients with bilateral saphenous vein insufficiency 
and RFA to the other leg. 
Methods
Sixty patients, 28 men and 32 women, with symptomatic 
great saphenous vein insufficiency in both lower extrem-
ities and presenting to the cardiovascular surgery clinic 
between January and December 2013, were enrolled. Pa-
tients’ ages ranged between 29 and 64 (mean 42.8 ± 10.0 
years). Sixty EVLA and 60 RFA procedures were applied 
to the saphenous veins in the lower extremities of the 60 
patients. Ethical committee approval was obtained before 
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the study began. Patients with unilateral vena saphena 
magna (VSM) insufficiency, patients receiving the same 
technique to both legs, patients not permitting interven-
tion on both legs in different sessions and patients who 
permitted interventions in both legs in separate sessions 
but in whom technical failure occurred in one or both 
sessions were excluded. Patients were classified on the 
basis of CEAP (clinical severity, etiology, anatomy and 
pathophysiology) before the procedure began. Venous 
clinical severity score (VCSS) values based on scoring of 
pre-procedural clinical symptoms and findings were re-
corded. EVLA and RFA procedures were decided on in 
the light of insufficiency in both existing VSM at colored 
Doppler ultrasonography (CDUSG) performed for diag-
nostic purposes. No advanced insufficiency or obstruc-
tion was determined in the deep veins of any extremity. 
A 12 W diode laser source with a wavelength of 1470 nm 
(Biolas-15D, Del YCHI GMBH, Duisburg, Germany) and 
radial fiber (EVLAS Circular-2, FG Group, Ankara, Tur-
key) were used for EVLA and an EVRF®: endovenous ra-
dio frequency CR45i device and catheter (F-Care Systems 
NV, Antwerp, Belgium) were used for RFA. Percutaneous 
entry was performed with a 21G needle accompanied by 
caudal section ultrasonography (USG) appropriate for 
treatment of saphenous vein with reflux determined in 
all patients under local anesthesia. Tumescent local an-
esthesia consisting of 20 mL 2% prilocaine, 500 mL 0.9% 
isotonic solution (+4ºC), 20 mL 8.4% sodium bicarbonate 
and 0.5 mg adrenalin was administered to the area sur-
rounding the saphenous vein with 19-21G needles guided 
by USG. 
Endovenous Laser Ablation Procedure
Laser energy was applied by adjusting the laser param-
eters (12 W, 1.2-1.8 mm/s withdrawal speed) in pulse 
mode (0.2 second interval) depending on the vein diam-
eter and depth from the skin of the saphenous vein, such 




Radiofrequency energy was applied to the saphenous vein 
in the form of 25 W every 0.5 cm from the distal aspect 
of the SFJ (50 W/cm). Analgesic (paracetamol) was pre-
scribed for all patients after both procedures. 
Pain during and after the procedure was assessed using a 
visual analog scale (VAS). Patients indicated the pain felt 
on a scale of 1 to 5. Patients’ analgesic requirements were 
recorded. An elastic bandage was applied for 2 days to 
the leg receiving the procedure. Compression socks were 
subsequently recommended for 3 months. Patients were 
encouraged to return to their daily activities as early as 
possible. Times to return to daily activities were recorded. 
Follow-ups were performed clinically on the second day 
post-procedure and both clinically and using CDUSG on 
the 1st week and at the first, third and sixth months. Sa-
phenous vein occlusion, recanalization, perforating veins 
and residual varicosities were recorded by CDUSG. Major 
and minor complications were investigated. No pake exci-
sion was performed on any patient during EVLA or RFA. 
Statistical Analysis
Data were expressed as mean ± standard deviation (SD) or 
as median and range. Demographic and clinical measures 
were tested using paired samples t tests for parametric 
variables and Wilcoxon signed ranks tests for non-nor-
mally distributed data. McNemar test was used to analyze 
quantitative data. All calculations were performed using 
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). P < 0.05 
was considered statistically significant.
Results
All patients had primary etiology, and pathophysiology 
was associated with reflux in the entire extremity. All pa-
tients receiving EVLA and RFA were symptomatic in both 
legs. No statistically significant difference was determined 
between legs on the basis of CEAP and VCSS classifica-
tion at preoperative assessment. Mean duration of reflux 
in the SFJ was 3.4 seconds in the EVLA group and 3.8 
seconds in the RFA group. EVLA and RFA procedures 
were performed on 120 saphenous veins. Mean diameters 
of saphenous veins receiving EVLA were 9.6 mm at the 
level of the SFJ and 8.2 mm at knee level. The equivalent 
values in patients receiving RFA were 10.3 mm and 8.4 
mm, respectively. Length of saphenous vein undergoing 
procedure was 27.4 cm in subjects receiving EVLA and 
26.5 cm in those receiving RFA. Depth of saphenous vein 
from the skin was 15.3 mm in the EVLA group and 14.7 
mm in the RFA group. Duration of procedures was 31.2 
minutes for EVLA and 32.7 minutes for RFA. No sig-
nificant difference was determined between the groups. 
Demographic and clinical findings are shown in detail in 
Table 1. Preoperative pain score on VAS was 1.4 in the 
EVLA group and 1.7 in the RFA group, although the dif-
ference was not significant. Postoperative pain score was 
1.2 in the EVLA group and 1.4 in the RFA group. The dif-
ference was statistically significant (P < 0.035). Postopera-
tive analgesic requirement was 1.7 units/day in the EVLA 
group and 1.9 units/day in the RFA group. The difference 
was not significant. Length of time to start postoperative 
activity was 0.9 days in the EVLA group and 1.3 days in 
the RFA group, and the difference was again significant 
(P < 0.001). Time to return to work was 1.8 days in the 
EVLA group and 2.1 days in the RFA group, and the dif-
ference was not significant. Postoperative data are shown 
in Table 2. Postoperative minor complications were deter-
mined in the form of induration, ecchymosis and edema. 
Induration developed in 69.0% of patients in the EVLA 
group and 79.3% of those in the RFA group. The differ-
ence was not significant. Ecchymosis developed in 31.0% 
of the patients in the EVLA group and in 51.7% of those 
in the RFA group. The difference was not significant. Ede-
ma developed in 27.6% of the patients in the EVLA group 
and 65.5% of those in the RFA group. The difference was 
statistically significant (P < 0.007). Induration, ecchymo-
sis and edema resolved entirely at the end of 2 weeks. No 
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major complication (such as DVT, pulmonary embolism 
or skin burn) was observed in any patient. Complica-
tions after endovenous laser therapy and RFA are shown 
in Table 3. When asked once both procedures had been 
performed which they were more satisfied with, 31% of 
patients responded RFA, 51.7% EVLA and 17.2% both. 
Recanalization developed in 4 saphenous veins in the RFA 
group during monitoring, a recanalization rate of 6.8%. 
Complete occlusion was determined in 60 (100%) saphe-
nous veins at sixth month follow-up after EVLA in the 
EVLA group.
Discussion
Chronic venous insufficiency (CVI) and lower extremity 
varices that develop in association with this are an im-
portant clinical condition that significantly affect quality 
of life and have socioeconomic consequences.15 Signifi-
cant progress has been made in the treatment of varicose 
veins in the last 10 years. Endovenous ablation techniques 
have to a large extent replaced surgery. Thermal endove-
nous procedures such as RFA and EVLA have become the 
most commonly used techniques. Several studies have 
compared these two different forms of ablation. There is 
no general consensus on which method is superior. Publi-
cations generally report that both methods have the same 
levels of successful ablation, but that pain levels and rates 
of complications following RFA are lower compared to 
EVLA.12,16-20 However, these studies have generally used 
low wavelength laser. Several recent studies suggest that 
better results are achieved with higher laser wavelengths. 
One recent study compared radial laser fiber at a wave-
length of 1470 nm and bare fiber at a wavelength of 980 
nm and reported better patient comfort with 1470 nm 
radial fiber.14 Therefore, if we really wish to compare the 
two methods, we need to compare 1470 nm radial laser 
and RFA. The most important factor determining patient 
comfort is sensation of pain. This may vary from person 
to person, and when the two techniques are compared in 
different patients it may be impossible to make a truly ob-
jective assessment due to variations in different patients’ 
pain thresholds. Our purpose was therefore to compare 
the effectiveness and side-effects of these methods by ap-
plying the two different ablation techniques to different 
legs in the same patient. No previous studies have com-
pared these two techniques applied to different extremi-
ties in the same patient. We determined ablation rates of 
100% in the EVLA group and 93.2% in the RFA group. 
The difference was not statistically significant, however. 
In their meta-analysis, van den Bos et al evaluated 119 
studies and determined success rates of 94% for EVLA 
and 84% for RF on the basis of results for 12 320 legs.21 
Almeida et al reported recanalization rates of 5.5% for 
RF and 1.7% for EVLA.16 Puggioni et al reported success 
rates at 1-month follow-up of 100% for EVLA and 96% 
for RF.17 This is because in performing ablation with RF 
the catheter has to touch the vein wall, while thermal ab-
lation is possible without laser energy making contact. All 
previous studies have reported that the greatest superiori-
ty of RF over EVLA is greater patient satisfaction.12,17-19 In 
our study, however, patient satisfaction was higher in the 
EVLA group, while better results for criteria such as intra-
operative and postoperative pain, postoperative analgesic 
requirement, return to activity and return to work were 
obtained in the EVLA group. Of these, postoperative pain 
and time to return to activity were statistically significant 
(P < 0.035 and P < 0.001, respectively). We attribute this 
both to the low wavelengths in previous studies and to 
the use of bare tip laser catheters. Since high wavelength 
laser rays use water as a chromophore they are better able 
to penetrate the vein wall. In addition, the radial dissemi-
nation of rays permits a more homogeneous contact with 
the vein wall and reduces the incidence of perforation. No 
procedure-related major complication (DVT, pulmonary 
embolism, skin burn) developed in this study. Minor com-
plication levels were lower in the EVLA group. The point 
that should not be forgotten here is that the majority of 
minor complications (hematoma, ecchymosis) occur not 
in association with the procedure but with the application 
of tumescent anesthesia. Careful application of tumescent 
Table 1. Demographic and Clinical Data
EVLA (n = 60) RFA (n = 60) P
VCSS 9.7 ± 2.5 9.9 ± 2.5 0.196
CEAP 3.2 ± 0.4 3.2 ± 0.4 1.000
VSM diameter (SFJ) mm 9.6 ± 1.7 10.3 ± 2.8 0.213
VSM diameter (knee) mm 8.2 ± 1.4 8.4 ± 2.3 0.633
Mean SFJ reflux time (s) 3.4 ± 1.4 3.8 ± 1.3 0.102
Distance from skin 15.3 ± 7.3 14.5 ± 7.3 0.212
Length of saphenous vein 27.4 ± 3.4 26.5 ± 6.5 0.108
Duration of procedure 31.2 ± 4.7 32.7 ± 6.5 0.205
Abbreviations: EVLA, endovenous laser ablation; RFA, 
radiofrequency ablation; VCSS, venous clinical severity score; 
CEAP, clinical severity, etiology, anatomy and pathophysiology; 
VSM, vena saphena magna; SFJ, saphenofemoral junction.
Table 2. Postoperative Data
EVLA (n = 60) RFA (n = 60) P
Pain (intraoperative)/day 1.4 ± 0.6 1.7 ± 0.8 0.074
Pain (postoperative)/day 1.2 ± 0.4 1.4 ± 0.5 0.035*
Analgesic requirement 1.7 ± 0.6 1.9 ± 0.4 0.063
Time to return to activity 0.9 ± 0.8 1.3 ± 1.1 0.001*
Time to return to work 1.8 ± 0.8 2.1 ± 1.2 0.549
Abbreviations: EVLA, endovenous laser ablation; RFA, 
radiofrequency ablation.
Table 3. Complications After Endovenous Laser Therapy and 
Radiofrequency Ablation
EVLA (n = 60) RFA (n = 60) P
Induration 20.7% 31.0% 0.508
Ecchymosis 31.0% 27.6% 0.146
Edema 27.6% 65.5% 0.007*
Paresthesia 0.0 0.0 -
Deep vein thrombosis 0.0 0.0 -
Pulmonary embolism 0.0 0.0 -
Abbreviations: EVLA, endovenous laser ablation; RFA, 
radiofrequency ablation.
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anesthesia will reduce these complications to a minimum. 
In that event, the most important difference between the 
two techniques will be sensation of pain and occlusion 
rate. Sensation of pain is lower in the EVLA group (with a 
1470 nm wavelength and radial fiber). 
Conclusion
Comparing the two techniques in the same patient in this 
study reduces patient-dependent factors to a minimum. 
Patient satisfaction can thus be assessed more objectively. 
In conclusion, EVLA and RFA have similar success rates. 
However, in terms of pain and patient satisfaction, EVLA 
at a wavelength of 1470 nm and using radial fiber is supe-
rior to RFA. 
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